BNP Paribas Asset Management
GSK icon

BNP Paribas Asset Management’s GSK GSK Stock Holding History

BNP Paribas Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1M Buy
479,106
+19,969
+4% +$1.06M 0.03% 529
2026
Q1 		$25.3M Buy
459,137
+202,257
+79% +$11M 0.03% 497
2025
Q4 		$12.6M Buy
+256,880
New +$12M 0.01% 639

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BNP Paribas Asset Management's GSK Position: Q2 2026 in Review

BNP Paribas Asset Management increased its GSK (GSK) stake by 4.3% in Q2 2026, buying an estimated $1.06M and bringing the position to 479,106 shares worth $25.1M. The position accounts for 0.03% of the portfolio, ranked #529.

BNP Paribas Asset Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $25.3M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • BNP Paribas Asset Management held 479,106 shares of GSK worth $25.1M as of Q2 2026.
  • BNP Paribas Asset Management bought 19,969 GSK shares in Q2 2026, an estimated $1.06M.
  • GSK made up 0.03% of BNP Paribas Asset Management's portfolio in Q2 2026, its #529 holding.
  • BNP Paribas Asset Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • BNP Paribas Asset Management's GSK position peaked at $25.3M in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.